company background image
8432 logo

TSH Biopharm TPEX:8432 Stock Report

Last Price

NT$64.20

Market Cap

NT$2.5b

7D

-4.3%

1Y

43.5%

Updated

13 Jun, 2024

Data

Company Financials

TSH Biopharm Corporation Limited

TPEX:8432 Stock Report

Market Cap: NT$2.5b

TSH Biopharm Corporation Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for TSH Biopharm
Historical stock prices
Current Share PriceNT$64.20
52 Week HighNT$69.20
52 Week LowNT$44.30
Beta0.16
1 Month Change-2.13%
3 Month Change17.58%
1 Year Change43.46%
3 Year Change44.43%
5 Year Change-6.41%
Change since IPO10.85%

Recent News & Updates

Recent updates

Weak Financial Prospects Seem To Be Dragging Down TSH Biopharm Corporation Limited (GTSM:8432) Stock

Feb 18
Weak Financial Prospects Seem To Be Dragging Down TSH Biopharm Corporation Limited (GTSM:8432) Stock

Is TSH Biopharm Corporation Limited (GTSM:8432) An Attractive Dividend Stock?

Jan 21
Is TSH Biopharm Corporation Limited (GTSM:8432) An Attractive Dividend Stock?

TSH Biopharm's (GTSM:8432) Shareholders Are Down 26% On Their Shares

Dec 16
TSH Biopharm's (GTSM:8432) Shareholders Are Down 26% On Their Shares

Shareholder Returns

8432TW PharmaceuticalsTW Market
7D-4.3%0.1%2.5%
1Y43.5%6.5%26.3%

Return vs Industry: 8432 exceeded the TW Pharmaceuticals industry which returned 6.5% over the past year.

Return vs Market: 8432 exceeded the TW Market which returned 26.3% over the past year.

Price Volatility

Is 8432's price volatile compared to industry and market?
8432 volatility
8432 Average Weekly Movement5.5%
Pharmaceuticals Industry Average Movement4.2%
Market Average Movement4.7%
10% most volatile stocks in TW Market8.5%
10% least volatile stocks in TW Market2.2%

Stable Share Price: 8432 has not had significant price volatility in the past 3 months.

Volatility Over Time: 8432's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
199976Sze-Yuan Yangwww.tshbiopharm.com

TSH Biopharm Corporation Limited develops and markets pharmaceutical products in Taiwan and Asia. It offers products for cardiovascular, central nervous, gastrointestinal, and others. The company was founded in 1999 and is headquartered in Taipei city, Taiwan.

TSH Biopharm Corporation Limited Fundamentals Summary

How do TSH Biopharm's earnings and revenue compare to its market cap?
8432 fundamental statistics
Market capNT$2.47b
Earnings (TTM)NT$92.24m
Revenue (TTM)NT$866.55m

26.7x

P/E Ratio

2.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
8432 income statement (TTM)
RevenueNT$866.55m
Cost of RevenueNT$423.17m
Gross ProfitNT$443.38m
Other ExpensesNT$351.14m
EarningsNT$92.24m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)2.40
Gross Margin51.17%
Net Profit Margin10.64%
Debt/Equity Ratio0%

How did 8432 perform over the long term?

See historical performance and comparison

Dividends

2.0%

Current Dividend Yield

53%

Payout Ratio

Does 8432 pay a reliable dividends?

See 8432 dividend history and benchmarks
When do you need to buy 8432 by to receive an upcoming dividend?
TSH Biopharm dividend dates
Ex Dividend DateJun 17 2024
Dividend Pay DateJul 12 2024
Days until Ex dividend4 days
Days until Dividend pay date29 days

Does 8432 pay a reliable dividends?

See 8432 dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.